Treatment with ketoprofen, a nonsteroidal anti-inflammatory drug that inhibits 5-lipoxygenase (5-LO) and cyclooxygenase, effectively reduced inflammation in a murine model of acquired lymphedema (Jiang et al, 2018). Here, ALOX5 is linked to lymphedema.